top of page

BRINGING

BIOLOGICS MEDICAL INNOVATION TO INTERNATIONAL MARKET

Scroll Down

KGBIO AT A GLANCE

 
Biotechnology company

T

KGbio is a clinical-stage biotech company backed by Kalbe and Genexine. Our focus is on licensing biologics and biosimilars in oncology and high-specialty areas, while also providing contract manufacturing services. Join us in bringing biologics medical innovation to international market.

Anchor 1
Doctor and Patient

Our Team

Made up of experienced professionals with diverse backgrounds and expertise, creating a culture of collaboration, excellence, and accountability that drives our success.

Business Meeting

Our Business

Our focus is on licensing in and licensing out novel biologics and biosimilars that improve patient outcomes and quality of life.

Drug and Syringe

Our Product

Our products cover several therapeutic areas, including oncology and high specialty areas.

Laboratory

Our Service

Provide cGMP contract development and manufacturing as the first and the pioneer of biopharmaceuticals in Indonesia

LATEST NEWS

April 27, 2024

Kalbe Launches Anemia Efepoetin Alfa, a Drug for Patients with Chronic Kidney Diseases

March 9, 2024

Kalbe Launches Serplulimab, Lung Cancer Therapeutic Drug

October 23, 2023

KGbio Received Market Approval for Efesa

businesspeople-meeting-office-hand-shake_edited_edited_edited.jpg

Join Us

We invite you to join us and get success to be part of KGbio

bottom of page